SCHEMBL32663296

SCHEMBL32663296

CCOC(=O)c1nn(CC)c(Br)c1C=O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
PDE4A P27815 5/20 0.39
PDE4B Q07343 5/20 0.39
PDE4C Q08493 5/20 0.39
PDE4D Q08499 5/20 0.39
USP2 O75604 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 5/20 0.36
LMNA P02545 4/20 0.36
ALDH1A1 P00352 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
ELANE P08246 2/20 0.35
KMT2A Q03164 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20477246 0.82 CYP19A1 (0.54) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL24709861 0.79 MEN1 (0.47) MAPTLMNAALDH1A1NPSR1KDM4E
SCHEMBL32663501 0.78 SMN1; SMN2 (0.38) SMN1; SMN2USP2CYP3A4MAPTLMNA
SCHEMBL7613 0.76 ALDH1A1 (0.57) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL12373440 0.74 SMN1; SMN2 (0.45) SMN1; SMN2USP2CYP3A4MAPTLMNA
SCHEMBL29952019 0.73 ELANE (0.44) SMN1; SMN2MAPTALDH1A1KDM4EELANE
SCHEMBL29956715 0.73 ELANE (0.46) SMN1; SMN2MAPTLMNAALDH1A1NPC1
SCHEMBL4693433 0.72 PDE4B (0.55) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL29955892 0.72 ELANE (0.45) SMN1; SMN2USP2CYP3A4MAPTLMNA
SCHEMBL26783067 0.72 PDE4D (0.41) SMN1; SMN2PDE4DUSP2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680608-A1 2,6-DIHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE DERIVATIVES AS ANTI-MALARIAL AGENTS MMV Medicines for Malaria Venture (CH) 2026-01-21 EP disclosed